ATC-0108 expressing BAG3 gene therapy (Affinia Therapeutics)

N/A

Report date: 2025/06/11 10:49:26

Base Information

Drug NameATC-0108 expressing BAG3 gene therapy (Affinia Therapeutics)
Drug Alias NameBAG3 gene therapy (Affinia Therapeutics)ATV-0134
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionBAG3 gene transference
TargetsBAG family molecular chaperone regulator 3
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAffinia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAffinia Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A